EMA Withdrawn: Exubera (Insulin human) — Pfizer Limited

View source ↗

Summary

EMA withdrew Exubera (insulin human) from the market; the product is no longer authorized for use in diabetes mellitus patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Status: Withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Pfizer Limited. Decision date: 09/07/2008